ARE:NYSEAlexandria Real Estate Equities, Inc. Analysis
Data as of 2026-03-14 - not real-time
$48.41
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Alexandria Real Estate Equities (ARE) is trading at $48.41, well below its 20‑day SMA of 52.54 and 50‑day SMA of 53.88, signaling a bearish price momentum that aligns with a bearish MACD and an RSI of 33.3, hinting at possible oversold conditions. The stock’s 30‑day volatility sits at a lofty 38.5% and volume trends are decreasing, suggesting heightened price swings and weakening market participation. Despite these technical headwinds, ARE offers an attractive 8.43% dividend yield with a modest payout ratio of 6.9%, and the recent declaration of a $0.72 per share cash dividend reinforces its income‑focused appeal. The DCF‑derived fair value of $34.96 implies a valuation gap, yet the model’s 23.2% upside/downside metric points to modest upside potential relative to current levels.
On the fundamentals side, the REIT posted a negative profit margin of -47.4% and a trailing EPS of -$8.44, reflecting significant impairments and a dip in same‑property NOI noted in the latest earnings release. However, operating cash flow remains robust at $1.41 B and free cash flow at $1.35 B, supporting its ability to sustain dividend payments. The balance sheet carries $12.76 B of debt with a debt‑to‑equity ratio of 66.6%, but recent cash tender offers for senior notes indicate management is actively managing leverage. The tenant base in high‑growth life‑science clusters and reported “robust leasing volume and strategic dispositions” provide a qualitative cushion for long‑term occupancy and rent growth.
On the fundamentals side, the REIT posted a negative profit margin of -47.4% and a trailing EPS of -$8.44, reflecting significant impairments and a dip in same‑property NOI noted in the latest earnings release. However, operating cash flow remains robust at $1.41 B and free cash flow at $1.35 B, supporting its ability to sustain dividend payments. The balance sheet carries $12.76 B of debt with a debt‑to‑equity ratio of 66.6%, but recent cash tender offers for senior notes indicate management is actively managing leverage. The tenant base in high‑growth life‑science clusters and reported “robust leasing volume and strategic dispositions” provide a qualitative cushion for long‑term occupancy and rent growth.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below short‑term moving averages indicating further downside risk
- High dividend yield provides income buffer
- Decreasing volume and elevated volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Cash tender offers may reduce leverage and improve balance‑sheet strength
- Robust leasing activity and strategic disposals support revenue stability
- Attractive dividend yield with low payout ratio
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Life‑science focused REIT model offers resilient tenant demand
- Persistent negative profit margins and high debt limit upside
- Strong cash flow generation supports dividend sustainability
Key Metrics & Analysis
REIT Metrics
P/FFO5.932954801174665
Technical Analysis
TrendBearish
RSI33.3
Support$48.18
Resistance$55.27
MA 20$52.54
MA 50$53.88
MA 200$65.96
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Risk Assessment
Beta0.83
Volatility38.47%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.